# Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo

> **NCT02317744** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 22 (actual)

## Conditions studied

- Binge Eating Disorder

## Interventions

- **DRUG:** Naltrexone and bupropion combination
- **OTHER:** Pill Placebo

## Key facts

- **NCT ID:** NCT02317744
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02317744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02317744, "Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT02317744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*